FindTrial
Sign In

A retrospective study on the clinical characteristics of tyrosinemia II type in neonatal period

A retrospective study on the clinical characteristics of tyrosinemia II type in neonatal period

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047993
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tyrosinemia II type

Interventions

Case group:Nil

Sponsors

Neonatal intensive care unit of the Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Time of onset: <=28 days after birth; 2.Children with clinical manifestations of organic acidemia and receiving diagnosis and treatment in the hospital; 3.Genetic analysis showed TAT gene mutation.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Onset time;—

Countries

China

Contacts

Public ContactYang Changshuan

Neonatal intensive care unit of the Faculty of Pediatrics, the Seventh Medical Center of PLA General Hospital

15011219446@163.com+86 15011219446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026